BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35421082)

  • 1. Abnormal global alternative RNA splicing in COVID-19 patients.
    Wang C; Chen L; Chen Y; Jia W; Cai X; Liu Y; Ji F; Xiong P; Liang A; Liu R; Guan Y; Cheng Z; Weng Y; Wang W; Duan Y; Kuang D; Xu S; Cai H; Xia Q; Yang D; Wang MW; Yang X; Zhang J; Cheng C; Liu L; Liu Z; Liang R; Wang G; Li Z; Xia H; Xia T
    PLoS Genet; 2022 Apr; 18(4):e1010137. PubMed ID: 35421082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The landscape of differential splicing and transcript alternations in severe COVID-19 infection.
    Mukherjee SB; Mukherjee S; Detroja R; Frenkel-Morgenstern M
    FEBS J; 2023 Jun; 290(12):3128-3144. PubMed ID: 36628954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection severity and mortality is modulated by repeat-mediated regulation of alternative splicing.
    Mehta P; Chattopadhyay P; Ravi V; Tarai B; Budhiraja S; Pandey R
    Microbiol Spectr; 2023 Aug; 11(5):e0135123. PubMed ID: 37604131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood RNA alternative splicing events as diagnostic biomarkers for infectious disease.
    Zhang Z; Sauerwald N; Cappuccio A; Ramos I; Nair VD; Nudelman G; Zaslavsky E; Ge Y; Gaitas A; Ren H; Brockman J; Geis J; Ramalingam N; King D; McClain MT; Woods CW; Henao R; Burke TW; Tsalik EL; Goforth CW; Lizewski RA; Lizewski SE; Weir DL; Letizia AG; Sealfon SC; Troyanskaya OG
    Cell Rep Methods; 2023 Feb; 3(2):100395. PubMed ID: 36936082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jumper enables discontinuous transcript assembly in coronaviruses.
    Sashittal P; Zhang C; Peng J; El-Kebir M
    Nat Commun; 2021 Nov; 12(1):6728. PubMed ID: 34795232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Methods to Study Human Transcript Variants in COVID-19 Infected Lung Cancer Cells.
    Sun J; Fahmi NA; Nassereddeen H; Cheng S; Martinez I; Fan D; Yong J; Zhang W
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
    Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
    J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19.
    An S; Li Y; Lin Y; Chu J; Su J; Chen Q; Wang H; Pan P; Zheng R; Li J; Jiang J; Ye L; Liang H
    Front Immunol; 2021; 12():756288. PubMed ID: 34777369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients.
    Mukherjee SB; Detroja R; Mukherjee S; Frenkel-Morgenstern M
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic nanopore long-read sequencing analysis of HIV-1 splicing events during the early steps of infection.
    Nguyen Quang N; Goudey S; Ségéral E; Mohammad A; Lemoine S; Blugeon C; Versapuech M; Paillart JC; Berlioz-Torrent C; Emiliani S; Gallois-Montbrun S
    Retrovirology; 2020 Aug; 17(1):25. PubMed ID: 32807178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betacoronavirus-specific alternate splicing.
    Karlebach G; Aronow B; Baylin SB; Butler D; Foox J; Levy S; Meydan C; Mozsary C; Saravia-Butler AM; Taylor DM; Wurtele E; Mason CE; Beheshti A; Robinson PN
    Genomics; 2022 Mar; 114(2):110270. PubMed ID: 35074468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.
    Wang X; Zhao Y; Yan F; Wang T; Sun W; Feng N; Wang W; Wang H; He H; Yang S; Xia X; Gao Y
    J Virol; 2021 Aug; 95(18):e0060021. PubMed ID: 34106002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.
    Lin H; Ma X; Xiao F; Su H; Shi Y; Liu Y; Song L; Zhang Z; Zhang C; Peng H
    FEBS J; 2021 Sep; 288(17):5163-5178. PubMed ID: 34228902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
    Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
    J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection.
    Mukherjee S; Banerjee B; Karasik D; Frenkel-Morgenstern M
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.
    Aschenbrenner AC; Mouktaroudi M; Krämer B; Oestreich M; Antonakos N; Nuesch-Germano M; Gkizeli K; Bonaguro L; Reusch N; Baßler K; Saridaki M; Knoll R; Pecht T; Kapellos TS; Doulou S; Kröger C; Herbert M; Holsten L; Horne A; Gemünd ID; Rovina N; Agrawal S; Dahm K; van Uelft M; Drews A; Lenkeit L; Bruse N; Gerretsen J; Gierlich J; Becker M; Händler K; Kraut M; Theis H; Mengiste S; De Domenico E; Schulte-Schrepping J; Seep L; Raabe J; Hoffmeister C; ToVinh M; Keitel V; Rieke G; Talevi V; Skowasch D; Aziz NA; Pickkers P; van de Veerdonk FL; Netea MG; Schultze JL; Kox M; Breteler MMB; Nattermann J; Koutsoukou A; Giamarellos-Bourboulis EJ; Ulas T;
    Genome Med; 2021 Jan; 13(1):7. PubMed ID: 33441124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
    Li J; Guo M; Tian X; Wang X; Yang X; Wu P; Liu C; Xiao Z; Qu Y; Yin Y; Wang C; Zhang Y; Zhu Z; Liu Z; Peng C; Zhu T; Liang Q
    Med; 2021 Jan; 2(1):99-112.e7. PubMed ID: 32838362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.
    Prokop JW; Hartog NL; Chesla D; Faber W; Love CP; Karam R; Abualkheir N; Feldmann B; Teng L; McBride T; Leimanis ML; English BK; Holsworth A; Frisch A; Bauss J; Kalpage N; Derbedrossian A; Pinti RM; Hale N; Mills J; Eby A; VanSickle EA; Pageau SC; Shankar R; Chen B; Carcillo JA; Sanfilippo D; Olivero R; Bupp CP; Rajasekaran S
    Front Immunol; 2021; 12():694243. PubMed ID: 34335605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.